Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


A new 2013 research report extends the benefit of BLIS K12™

From: BLIS Technologies Ltd (NZX:BLT)

MediaPak: National Pak

Date: Friday, 11 Dec 2013

Release: Immediate

A new 2013 research report extends the benefit of BLIS K12™ probiotic

BLIS Technologies Ltd (NZX:BLT) announces another clinical study, just published this month, which further supports the effectiveness of BLIS K12™ oral cavity probiotic for preventing ear and throat infections. Published in the medical science journal, Expert Opinion on Biological Therapy, an Italian research team demonstrated that they could prevent the reoccurrence of common ear and throat infections, such as strep throat infection and tonsillitis by more than 83% in adults. The study followed 40 adults with a history of recurrent ear and throat infection and examined the effect of 90 days of treatment with either the BLIS K12™ probiotic or a placebo. Researchers concluded “The regular use of BLIS K12 appears to have effected a substantial reduction in the incidence of recurrent oral streptococcal pathology, reducing the requirement for these BLIS K12-treated individuals to be exposed to therapeutic courses of antibiotics.”

Di Pierro, F., et al. (2013). Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opinion on Biological Therapy.

This paper has been published just two months after a similar research paper also concluded that regular use of BLIS K12 in children could reduce the incidence of strep throat infection (including tonsillitis) by more than 92%. The children examined in this earlier study, previously had a recurrence rate for strep throat infection of nearly 4 times per year, however those children who then were assigned to the treatment with the BLIS K12™ probiotic dropped dramatically their rate of infection to the equivalent of just one incidence, every 4 years.

BLIS Technologies CEO, Dr Barry Richardson said, “We have known from our own work over several years about the effectiveness of the BLIS K12™ probiotic in treating and preventing certain infections of the throat and upper airways but finally, we have an independent research group that has now corroborated these findings. It is reassuring to us to know that BLIS K12™ has been independently supported as being highly efficacious in both children and adults.”

Dr Richardson said that he has seen a growing awareness among healthcare professional in New Zealand, pharmacists, dentist and doctors of benefits of BLIS K12™ probiotic for mouth and throat and has seen an increasing acceptance to consider BLIS K12™ probiotic as an option when managing the health of their patients, both young and old.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Internet: NZ Govt Lifts Target Speeds For Rural Broadband

The government has lifted its expectations on faster broadband speeds for rural New Zealand as it targets increased spending on research and development in the country's information and communications technology sector, which it sees as a key driver for export growth. More>>


Banks: Westpac Keeps Core Government Transactions Contract

The local arm of Westpac Banking Corp has kept its contract with the New Zealand government to provide core transactions, but will have to share peripheral services with its rivals. More>>


Science Investment Plan: Universities Welcome Statement

Universities New Zealand has welcomed the National Statement of Science Investment released by the Government today... this is a critical document as it sets out the Government’s ten-year strategic direction that will guide future investment in New Zealand’s science system. More>>


Scouring: Cavalier Merger Would Extract 'Monopoly Rents' - Godfrey Hirst

A merger of Cavalier Wool Holdings and New Zealand Wool Services International's two wool scouring operations would create a monopoly, says carpet maker Godfrey Hirst. The Commerce Commission on Friday released its second draft determination on the merger, maintaining its view that the public benefits would outweigh the loss of competition. More>>


Scoop Review Of Books: She Means Business

As Foreman says in her conclusion, this is a business book. It opens with a brief biographical section followed by a collection of interesting tips for entrepreneurs... More>>


Hourly Wage Gap Grows: Gender Pay Gap Still Fixed At Fourteen Percent

“The totally unchanged pay gap is a slap in the face for women, families and the economy,” says Coalition spokesperson, Angela McLeod. Even worse, Māori and Pacific women face an outrageous pay gap of 28% and 33% when compared with the pay packets of Pākehā men. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news